Clinical value of molecular markers as diagnostic and prognostic tools to guide treatment of thyroid cancer.

Molecular testing needs to be implemented into the local evidence based clinical management thyroid nodule/cancer pathways to improve its diagnostic and prognostic value and to optimize cost-effectiveness. This article is protected by copyright. All rights reserved.